There has been constant research for the development of
novel molecules providing immunity against fatal diseases such as Zika virus
and different types of cancers. For instance, in June 2016, Inovio
Pharmaceuticals, Inc. stated the commencement of phase I clinical trial for
their Zika DNA vaccine named GLS-5700. The vaccines administered to prevent
children from several non-infectious and infectious diseases are known as
pediatric vaccines. These vaccines are heat-killed or inactivated viruses that
lose their pathogenicity, i.e., the ability to cause a disease.
Moreover, these inactivated antigens can stimulate the
immune system to produce antibodies against the infected virus. Thus, they
assist the immune system in protecting itself from infectious or non-infectious
diseases in the future. Currently, immunization prevents an estimated 2-3
million deaths every year. Furthermore, about 1.5 million deaths can be
prevented through improved global coverage for vaccination.
The Worldwide Pediatric Vaccines Market is expected to
grow at a CAGR of ~10.6% during 2017 to 2023. There are different pediatric
vaccines accessible in the market, for example, pneumococcal immunization,
polio antibody, rotavirus immunization, MMR immunization, flu immunization,
hepatitis B antibody, meningococcal immunization, and Hib antibody.
However, low accessibility to remote areas, increasing
availability of biosimilars at low rates, increasing cost of vaccines, limited
or no access to healthcare services in developing and under-developed
countries, low healthcare spending, and less medical coverage for pediatric
vaccination are some of the challenges which might hamper the growth of the
global pediatric vaccines market in future.
Global
Pediatric Vaccines Market Segmentation:
The Global Pediatric Vaccines Market has been segmented
on the basis of type, technology, disease indication, and route of
administration. On the basis of type, the global pediatric vaccines market is
segmented into monovalent vaccines, multivalent vaccines, and others.
On the basis of technology, the global pediatric vaccines
market is segmented into synthetic vaccines, dendritic cells vaccines,
conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines,
toxoid vaccines, recombinant vaccines, and others.
On the basis of disease indication, the global
pediatric vaccines market is segmented into MMR (Measles, Mumps, and Rubella),
polio, Haemophilus influenza type B, pneumococcal disease, meningococcal
disease, influenza, DTP (Diphtheria, Tetanus, Pertussis), hepatitis, varicella,
rotavirus, combination vaccines and others. On the basis of route of
administration, the global pediatric vaccines market is segmented into
intramuscular administration, subcutaneous administration, oral administration,
and other routes of administration
World
Pediatric Vaccines Market Key Players:
Some of the key players in the global pediatric
vaccines market are GlaxoSmithKline plc (U.K.), Pfizer, Inc. (U.S.), Merck
& Co., Inc. (U.S.), Sanofi Pasteur SA (France), Astellas Pharma Inc.
(Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), Johnson
& Johnson (U.S.), MedImmune, LLC (U.S.), Serum Institute of India Pvt. Ltd.
(India), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation
(Japan), Daiichi Sankyo (Japan), Protein Sciences Corporation (U.S.), Grifols
(Spain), Crucell (Netherlands), Bharat Biotech (India), Kaketsuken (U.S.),
Panacea Biotec (India), Baxter International (U.S.), Zydus Cadila (India),
Nuron (U.S.), S K Chemicals (South Korea), Dynavax Technologies (U.S.), Bharat
Immunologicals and Biologicals (India), Lupin Pharmaceuticals, Inc. (India),
Indian Immunologicals (India), Novartis AG (Switerzland), LG Life Sciences
(India), Shenzhen Kangtai Biological Products (China), Sinovac Biotech (China),
Bio Med (India), AstraZeneca (UK), bioCSL Inc. (U.S.), Valeant Pharmaceuticals
(U.S.), Takeda Pharmaceutical (Japan) and others.
Pediatric
Vaccines Market Regional Analysis:
The Global Pediatric Vaccines Market consists of four
regions such as the Americas, Europe, Asia Pacific, and the Middle East and
Africa.
The Americas region accounted for the largest market
share of the global pediatric vaccines market owing to the growing initiatives
by the U.S. Department of Health and Human Services (HHS) to reduce the
occurrence rate of infectious diseases. Such factors along with the growing
immunization will fuel the U.S. market.
The European pediatric vaccines market is urged due to
the superior government spending such as NHS (Nation Healthcare Service) for
the development of the pharmaceutical and medical industries. The Asia Pacific
region is expected to grow rapidly during the forecast period owing to the
growing healthcare sector in leading regions such as China and India. The
Middle Eastern region is expected to grow at a steady pace owing to factors
such as rising R&D activities in the healthcare sector and extensive
development of healthcare infrastructure.
TABLE
OF CONTENT FOR PEDIATRIC VACCINES MARKET RESEARCH REPORT – GLOBAL FORECAST TILL
2023:
Chapter
1. Report Prologue
Chapter
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Disease Indication Trends & Assessment
TOC
Continued..!
About
US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone:
+1
646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment